The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice
GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet cells, promotion of islet cell proliferation and minimal side effects
GIP receptor activation may further support insulin release and influence fat metabolism
This can lead to better sex
If hair preservation is a top priority and the primary goal is moderate weight management rather than substantial loss, these older compounds might warrant discussion with a prescriber
For weight loss, name-brand semaglutide (Wegovy) comes in six FDA-approved doses for weekly injection (0.25, 0.5, 1, 1.7, 2.4, and 7.2 mg) and four FDA-approved oral doses for daily ingestion (1.5, 4, 9, and 25 mg)